Trial designs used to study neuroprotective therapy in Parkinson's disease-Reference-Cited by-同舟云学术

Trial designs used to study neuroprotective therapy in Parkinson's disease

Published:2012-08-23 Issue:1 Volume:28 Page:86-95
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord

Author:

Lang Anthony E.¹,Melamed Eldad²,Poewe Werner³,Rascol Olivier⁴

Affiliation:

1. Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J Safra Program in Parkinson's Disease; Toronto Western Hospital; Toronto; Ontario; Canada

2. The Norma and Alan Aufzien Chair for Resarch of Parkinson's Disease; Tel Aviv University; Sackler School of Medicine; Tel Aviv; Israel

3. Department of Neurology; Innsbruck Medical University; Innsbruck; Austria

4. Clinical Investigation Center and Department of Clinical Pharmacology and Neurosciences; CIC9302 INSERM and UMR825; Toulouse University Hospital; University of Toulouse-3; Toulouse; France

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference49 articles.

1. Clinical trials of disease-modifying therapies for neurodegenerative diseases: the challenges and the future;Lang;Nat Med,2010

2. Why have we failed to achieve neuroprotection in Parkinson's disease?;Olanow;Ann Neurol,2008

3. Defining disease-modifying therapies for PDA-a road map for moving forward;Olanow;Mov Disord,2010

4. Timing of treatment initiation in Parkinson's disease: a need for reappraisal?;Schapira;Ann Neurol,2006

5. Interpreting the results of Parkinson's disease clinical trials: time for a change;Holford;Mov Disord,2011

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using sustained vowels to identify patients with mild Parkinson’s disease in a Chinese dataset;Frontiers in Aging Neuroscience;2024-05-03

2. A multimodal dataset of real world mobility activities in Parkinson’s disease;Scientific Data;2023-12-20

3. An International Multi-Stakeholder Delphi Survey Study on the Design of Disease Modifying Parkinson’s Disease Trials;Journal of Parkinson's Disease;2023-12-19

4. Serum Neurofilament Predicts Mortality and Indicates Accelerated Neurodegeneration in Late-Stage Parkinson’s Disease;2023-05-18

5. Lifestyle Interventions for the Prevention of Parkinson Disease;Neurology;2022-08-15